Overall survival of patients with thyroid cancer in Martinique (2008-2018).
1/5 보강
[BACKGROUND] Thyroid cancer (TC) overall survival at 5 years was estimated at 97% in mainland France over 2010-2015.
- p-value p = 0.01
- HR 3.1
APA
Lin L, Almont T, et al. (2023). Overall survival of patients with thyroid cancer in Martinique (2008-2018).. BMC cancer, 23(1), 739. https://doi.org/10.1186/s12885-023-11072-1
MLA
Lin L, et al.. "Overall survival of patients with thyroid cancer in Martinique (2008-2018).." BMC cancer, vol. 23, no. 1, 2023, pp. 739.
PMID
37563603
Abstract
[BACKGROUND] Thyroid cancer (TC) overall survival at 5 years was estimated at 97% in mainland France over 2010-2015. Its prognosis is known to be affected by patient age, tumor histology, size, and extension. This study aims to describe overall survival of thyroid cancer patients diagnosed between 2008 and 2018 in Martinique.
[METHODS] We included in this retrospective analytical study all patients who were diagnosed with thyroid cancer. An overall survival analysis at 1, 3 and 5 years of thyroid cancer patients diagnosed in Martinique from 2008 to 2018 was conducted. Prognostic factors associated with survival have been identified. Stage at diagnosis and patterns of care among thyroid cancer patients were analyzed.
[RESULTS] A total of 323 thyroid cancer patients were registered between 2008 and 2018. Papillary carcinomas represented 83% of diagnoses. Local stage or locally advanced invasion was found in 264 (88%) patients. 221 Multidisciplinary Teams reports files were reviewed. The overall survival observed in this population is 97% [93-99] at 1 year, 93% [88-97] at 3 years and 91% [85-95] at 5 years. Anaplastic, poorly differentiated and medullar tumors had lower survival rates at 5 years (39% [13-65]) compared to papillary tumors (93% [89-96]). We found that metastatic stage at diagnosis (HR = 3.1[1.3-7.6]; p = 0.01) and tumor size > 3 cm (HR = 2.7 [1.1-6.3]) were independent prognostic factors for OS in our population.
[CONCLUSIONS] The survival rates of thyroid cancer in Martinique are comparable to those observed in France.
[METHODS] We included in this retrospective analytical study all patients who were diagnosed with thyroid cancer. An overall survival analysis at 1, 3 and 5 years of thyroid cancer patients diagnosed in Martinique from 2008 to 2018 was conducted. Prognostic factors associated with survival have been identified. Stage at diagnosis and patterns of care among thyroid cancer patients were analyzed.
[RESULTS] A total of 323 thyroid cancer patients were registered between 2008 and 2018. Papillary carcinomas represented 83% of diagnoses. Local stage or locally advanced invasion was found in 264 (88%) patients. 221 Multidisciplinary Teams reports files were reviewed. The overall survival observed in this population is 97% [93-99] at 1 year, 93% [88-97] at 3 years and 91% [85-95] at 5 years. Anaplastic, poorly differentiated and medullar tumors had lower survival rates at 5 years (39% [13-65]) compared to papillary tumors (93% [89-96]). We found that metastatic stage at diagnosis (HR = 3.1[1.3-7.6]; p = 0.01) and tumor size > 3 cm (HR = 2.7 [1.1-6.3]) were independent prognostic factors for OS in our population.
[CONCLUSIONS] The survival rates of thyroid cancer in Martinique are comparable to those observed in France.
🏷️ 키워드 / MeSH
같은 제1저자의 인용 많은 논문 (5)
- Preliminary clinical experience of robot-assisted surgery in treatment with genioplasty.
- Thermal modulation enhances antitumour immunity and improves immunotherapy responses in lung cancer.
- Epigenetic Metal-Organic Framework Nanoagonist Overcomes Triple Defenses to Enable Effective Chemo-Metalloimmunotherapy in Platinum-Resistant Ovarian Cancer.
- INSR/AKT1 axis promotes cells proliferation and migration in acute myeloid leukemia.
- EFNA3-mediated autophagy suppression drives breast cancer proliferation, EMT and metastasis via PI3K/AKT/mTOR axis.